Xenetic Biosciences Inc.

NASDAQ: XBIO · Real-Time Price · USD
2.92
-0.07 (-2.34%)
At close: Aug 14, 2025, 3:55 PM
2.81
-3.93%
Pre-market: Aug 15, 2025, 07:58 AM EDT

Xenetic Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.17M 8.98M 13.1M 18.24M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
313.92K 1.02M 1.07M 1.09M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a 603.83K n/a n/a
Total Current Assets
6.59M 9.59M 13.65M 18.72M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
313.92K 1.02M 1.07M 1.09M
Total Assets
6.9M 10.61M 14.72M 19.82M
Account Payables
283.62K 240.83K 287.36K 362.47K
Deferred Revenue
n/a n/a n/a -27.04K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
34.2K 48.26K n/a n/a
Total Current Liabilities
894.26K 809.59K 1.07M 1.42M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 287.36K n/a
Total Liabilities
894.26K 809.59K 1.07M 1.42M
Total Debt
n/a n/a n/a 27.04K
Common Stock
1.54K 1.54K 15.19K 13.46K
Retained Earnings
-197.19M -193.23M -189.1M -182.55M
Comprehensive Income
253.73K 253.73K 253.73K 253.73K
Shareholders Equity
6.01M 9.8M 13.65M 18.39M
Total Investments
n/a n/a n/a n/a